1. Home
  2. AFMD vs OPTX Comparison

AFMD vs OPTX Comparison

Compare AFMD & OPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • OPTX
  • Stock Information
  • Founded
  • AFMD 2000
  • OPTX 1981
  • Country
  • AFMD Germany
  • OPTX United States
  • Employees
  • AFMD N/A
  • OPTX N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • OPTX Blank Checks
  • Sector
  • AFMD Health Care
  • OPTX Finance
  • Exchange
  • AFMD Nasdaq
  • OPTX Nasdaq
  • Market Cap
  • AFMD 55.6M
  • OPTX 51.9M
  • IPO Year
  • AFMD 2014
  • OPTX N/A
  • Fundamental
  • Price
  • AFMD $3.65
  • OPTX $1.49
  • Analyst Decision
  • AFMD Strong Buy
  • OPTX
  • Analyst Count
  • AFMD 5
  • OPTX 0
  • Target Price
  • AFMD $16.25
  • OPTX N/A
  • AVG Volume (30 Days)
  • AFMD 98.0K
  • OPTX 58.5K
  • Earning Date
  • AFMD 11-14-2024
  • OPTX 11-25-2024
  • Dividend Yield
  • AFMD N/A
  • OPTX N/A
  • EPS Growth
  • AFMD N/A
  • OPTX 81.79
  • EPS
  • AFMD N/A
  • OPTX 0.01
  • Revenue
  • AFMD $7,959,927.00
  • OPTX $28,126,356.00
  • Revenue This Year
  • AFMD N/A
  • OPTX N/A
  • Revenue Next Year
  • AFMD $48.98
  • OPTX N/A
  • P/E Ratio
  • AFMD N/A
  • OPTX $126.33
  • Revenue Growth
  • AFMD N/A
  • OPTX N/A
  • 52 Week Low
  • AFMD $2.92
  • OPTX $0.95
  • 52 Week High
  • AFMD $8.95
  • OPTX $10.43
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 55.19
  • OPTX 58.13
  • Support Level
  • AFMD $3.63
  • OPTX $1.43
  • Resistance Level
  • AFMD $3.98
  • OPTX $1.59
  • Average True Range (ATR)
  • AFMD 0.24
  • OPTX 0.10
  • MACD
  • AFMD 0.04
  • OPTX 0.01
  • Stochastic Oscillator
  • AFMD 55.65
  • OPTX 82.66

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

Share on Social Networks: